Babio Launches High-Performance Brain Heart Infusion Broth for Global Microbiology Labs

Babio Launches High-Performance Brain Heart Infusion Broth for Global Microbiology Labs

Jinan, China — Babio Biotechnology Co., Ltd. (BABIO), a trusted Chinese manufacturer of diagnostic reagents and culture media, has introduced its Brain Heart Infusion (BHI) Broth, a ready-to-use liquid medium designed for high-efficiency bacterial cultivation.

The BHI Broth is formulated to support fastidious microorganisms, including Streptococcus, Neisseria, and Haemophilus, making it ideal for clinical diagnostics, pharmaceutical sterility testing, and microbial limit assays in food, water, and research laboratories.

With a rich nutrient composition derived from beef heart and porcine brain infusions, Babio’s BHI Broth ensures robust microbial growth, high consistency, and global compatibility across manual and automated microbiological systems.

Already gaining traction among researchers in Europe, North America, Africa, and Southeast Asia, this pre-prepared broth eliminates the need for autoclaving, reduces contamination risk, and streamlines lab workflows — a key factor in accelerating pathogen recovery and antimicrobial testing.

As an ISO- and GMP-certified manufacturer, Babio Biotechnology continues to deliver world-class microbiological media to over 60 countries. For more details or partnership inquiries, visit the official website: https://www.babiocorp.com

#BrainHeartInfusionBroth #BabioBiotechnology #CultureMedia #ClinicalDiagnostics #MicrobiologyTesting #PharmaceuticalQC #LaboratorySupplies #GlobalDiagnostics